# Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System

Study · id `cardio:ct-nct01726257` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01726257](<https://clinicaltrials.gov/study/NCT01726257>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01726257

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 333 participants.

## Technical summary

Registry record NCT01726257. Allocation not applicable; no masking; primary purpose treatment. Start 2013-12 (actual); primary completion 2016-06 (actual). Results posted on 2024-11-06.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 333 participants (enrolled count; ClinicalTrials.gov record NCT01726257, source copy `cardio:ctgov-nct01726257-2025-02-28`, retrieved 2026-11-18)
- Started: 2013-12 (actual) (ClinicalTrials.gov record NCT01726257, source copy `cardio:ctgov-nct01726257-2025-02-28`, retrieved 2026-11-18)
- Primary completion: 2016-06 (actual) (ClinicalTrials.gov record NCT01726257, source copy `cardio:ctgov-nct01726257-2025-02-28`, retrieved 2026-11-18)
- Completion: 2022-12 (actual) (ClinicalTrials.gov record NCT01726257, source copy `cardio:ctgov-nct01726257-2025-02-28`, retrieved 2026-11-18)
- Results first posted: 2024-11-06 (ClinicalTrials.gov record NCT01726257, source copy `cardio:ctgov-nct01726257-2025-02-28`, retrieved 2026-11-18)
- Countries: United States; Germany; Netherlands; United Kingdom (ClinicalTrials.gov record NCT01726257, source copy `cardio:ctgov-nct01726257-2025-02-28`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01726257-2025-02-28`, retrieved 2026-11-18)

## The registry's words

- Brief title: Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
- Acronym: EVAS1
- Condition: Abdominal Aortic Aneurysm (AAA)
- Intervention (Device): Nellix System
- Lead sponsor: Endologix
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Endologix (`cardio:org-endologix`)

## Provenance

Content hash: e74fff6f0e324674137f7da3279ea8cdc7aba930cc18ea7437d5f2b75bf9afd0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
